Clinical Trial Update: Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating AR882 alone or in combination with allopurinol for tophaceous gout has completed, focusing on efficacy and safety in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Gouty Arthritis
• Hyperuricemia
• Tophaceous Gout

Drugs mentioned

• AR882
• Allopurinol (Allopurinol)

Snippet

Sponsor: Arthrosi Therapeutics | Conditions: Gout, Arthritis, Gouty | Phase 2 | Status: COMPLETED